Tata Consultancy Services Ltd.

BSE: 532540 | NSE: TCS
Large Cap | IT - Software
2268.25
66.45 (3.02%)
< Home < Back

TCS launches COVID-19 testing, vaccine management suite

Date: 04-03-2021

Tata Consultancy Services (TCS) has launched COVID-19 testing and vaccine management suite. This suite of modular, easy-to-deploy solutions streamlines every stage of the end-to-end testing and vaccination journeys, enabling more individuals to get tested and vaccinated faster and return to normal life experiences.

Behind every vaccination or test for COVID-19 is the highly complex orchestration of multiple stakeholders - from manufacturing to transportation, allocation to storage, distribution to scheduling, and reporting to monitoring. There is an opportunity to provide a seamless process across the entire value chain to prevent issues that could slow down testing and vaccinations.

In designing its new solution suite, TCS emulated the example of successful retailers and other consumer-centric enterprises and adopted their proven, people-centric approach to optimizing the testing and vaccination ecosystems. Further, given the urgency of the problem, re-purposing proven use cases from other consumer-facing industries helped speed up the design of an end-to-end solution.

TCS is an IT services, consulting and business solutions organization that has been partnering with many of the world’s largest businesses in their transformation journeys for over 50 years.